Syncom Healthcare Limited
NSE: SYNCOM
NSE
4.25
0.05 (1.19%)
Prev Close
4.2
Open Price
4.1
Volume
332,739
Today Low / High
3.95 / 4.3
52 WK Low / High
2.2 / 5.6
Range
4 - 4
Currently, the stock is trading on the National Stock Exchange (NSE). The stock price stands at 4.25, with a change of 0.05000019 (1.1904808%). The expected target range on the NSE is between 4 - 4. The stock is trending upwards on the NSE, which could present a good opportunity for potential investors.
Syncom Healthcare Limited Graph
Syncom Healthcare Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Syncom Healthcare Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 4.25, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 4.25 | 4.29 | 3.86 - 4.72 |
| 4.34 | 3.47 - 5.20 | ||
| 4.38 | 3.06 - 5.69 | ||
| Bearish Scenario | 4.25 | 4.21 | 3.79 - 4.63 |
| 4.17 | 3.33 - 5.00 | ||
| 4.12 | 2.89 - 5.36 |
Overview of Syncom Healthcare Limited
ISIN
INE602K01014
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
0
Market Cap
0
Last Dividend
0
Official Website
IPO Date
2010-02-15
DCF Diff
N/A
DCF
0
Financial Ratios Every Investor Needs
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-03-31 | 1.83 Cr | 6.25 Cr | -4.41 Cr | -2.4088 | 0.00 Cr | 0.00 Cr | -5.30 Cr | -4.91 Cr | -1.23 | -3.30 Cr | -2.6798 |
| 2020-03-31 | 19.97 Cr | 20.74 Cr | -0.77 Cr | -0.0387 | 0.00 Cr | 0.52 Cr | -11.69 Cr | -11.72 Cr | -2.93 | -9.40 Cr | -0.5869 |
| 2019-03-31 | 64.12 Cr | 56.91 Cr | 7.21 Cr | 0.1124 | 0.00 Cr | 0.89 Cr | -4.79 Cr | -11.42 Cr | -2.85 | -1.85 Cr | -0.1781 |
| 2018-03-31 | 41.53 Cr | 24.20 Cr | 17.33 Cr | 0.4174 | 0.00 Cr | 0.87 Cr | -14.62 Cr | -78.24 Cr | -19.56 | -15.72 Cr | -1.8838 |
| 2017-03-31 | 55.55 Cr | 41.61 Cr | 13.93 Cr | 0.2509 | 0.00 Cr | 0.51 Cr | -91.11 Cr | -167.83 Cr | -41.96 | -89.76 Cr | -3.0214 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-03-31 | 4.08 Cr | 16.38 Cr | 33.71 Cr | -17.3248 Cr | 24.18 Cr | 20.10 Cr | 0.45 Cr | 9.33 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 21.6050 Cr |
| 2020-03-31 | 0.38 Cr | 17.83 Cr | 30.24 Cr | -12.4152 Cr | 23.66 Cr | 23.28 Cr | 2.01 Cr | 11.14 Cr | 0.91 Cr | 0.00 Cr | 0.00 Cr | 18.2148 Cr |
| 2019-03-31 | 0.20 Cr | 49.46 Cr | 50.36 Cr | -0.9030 Cr | 23.92 Cr | 23.72 Cr | 7.09 Cr | 13.42 Cr | 0.81 Cr | 0.00 Cr | 0.00 Cr | 38.1590 Cr |
| 2018-03-31 | 0.11 Cr | 60.87 Cr | 50.40 Cr | 10.4709 Cr | 24.91 Cr | 24.79 Cr | 9.53 Cr | 16.23 Cr | 1.12 Cr | 0.00 Cr | -0.44 Cr | 45.2041 Cr |
| 2017-03-31 | 0.49 Cr | 130.44 Cr | 41.77 Cr | 88.8860 Cr | 26.40 Cr | 25.91 Cr | 10.80 Cr | 19.81 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 33.1867 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-03-31 | 2.4221 Cr | -3.0712 Cr | 0.5075 Cr | 2.4221 Cr | 3.6993 Cr | 4.0792 Cr | 0.0000 Cr | -4.9096 Cr | 0.0000 Cr | 0.0000 Cr | 1.5668 Cr |
| 2020-03-31 | -0.0094 Cr | 0.4577 Cr | -0.2646 Cr | -0.0210 Cr | 0.1838 Cr | 0.3799 Cr | -0.0116 Cr | -11.7189 Cr | 0.0000 Cr | 0.0000 Cr | 5.0819 Cr |
| 2019-03-31 | 1.3203 Cr | -0.2503 Cr | -0.9873 Cr | 1.2120 Cr | 0.0827 Cr | 0.1961 Cr | -0.1083 Cr | -11.4177 Cr | 0.0000 Cr | 0.0000 Cr | 2.4351 Cr |
| 2018-03-31 | 5.6539 Cr | -0.9673 Cr | -4.8469 Cr | 5.5196 Cr | -0.1603 Cr | 0.1133 Cr | -0.1343 Cr | -78.2356 Cr | 0.0000 Cr | 0.0000 Cr | 1.2746 Cr |
| 2017-03-31 | -40.4974 Cr | 49.8445 Cr | -9.9375 Cr | -44.4781 Cr | -0.5905 Cr | 0.2736 Cr | -3.9807 Cr | -167.8265 Cr | 0.0000 Cr | 0.0000 Cr | 2.3803 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2021-06-30 | 0.35 Cr | 0.34 Cr | 0.01 Cr | 0.0312 | -1.16 Cr | -1.11 Cr | -0.28 | -0.72 Cr | -3.1412 |
| 2021-03-31 | 0.45 Cr | 0.61 Cr | -0.16 Cr | -0.3519 | -1.34 Cr | -1.07 Cr | -0.27 | -0.90 Cr | -2.3459 |
| 2020-12-31 | 0.45 Cr | 0.69 Cr | -0.24 Cr | -0.5213 | -1.29 Cr | -1.27 Cr | -0.32 | -0.82 Cr | -2.7993 |
| 2020-09-30 | 0.60 Cr | 0.56 Cr | 0.05 Cr | 0.0779 | -1.16 Cr | -1.08 Cr | -0.27 | -0.49 Cr | -1.7797 |
| 2020-06-30 | 0.32 Cr | 0.71 Cr | -0.39 Cr | -1.2276 | -1.51 Cr | -1.50 Cr | -0.37 | -0.98 Cr | -4.6862 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2021-03-31 | 0.26 Cr | 3.82 Cr | 4.08 Cr | 0.38 Cr | 0.45 Cr | 5.54 Cr | 9.33 Cr | 16.38 Cr | 33.71 Cr |
| 2020-09-30 | 3.68 Cr | 0.78 Cr | 4.46 Cr | 0.00 Cr | 0.99 Cr | 6.91 Cr | 10.20 Cr | 18.63 Cr | 33.62 Cr |
| 2020-03-31 | 0.38 Cr | 0.00 Cr | 0.38 Cr | 0.00 Cr | 2.01 Cr | 4.70 Cr | 11.14 Cr | 17.83 Cr | 30.24 Cr |
| 2019-09-30 | 0.29 Cr | 0.81 Cr | 1.09 Cr | 0.00 Cr | 2.50 Cr | 14.60 Cr | 12.33 Cr | 28.61 Cr | 30.33 Cr |
| 2019-03-31 | 0.20 Cr | 0.00 Cr | 0.20 Cr | 0.00 Cr | 7.09 Cr | 34.40 Cr | 13.42 Cr | 49.46 Cr | 50.36 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2019-06-30 | -0.79 Cr | 0.33 Cr | -0.03 Cr | -0.25 Cr | 0.02 Cr | 0.05 Cr | 0.03 Cr | -0.03 Cr | 0.30 Cr |
| 2019-03-31 | -8.96 Cr | 0.33 Cr | -0.03 Cr | -0.25 Cr | 0.02 Cr | 0.05 Cr | 0.03 Cr | -0.03 Cr | 0.30 Cr |
| 2018-12-31 | -2.84 Cr | 0.33 Cr | -0.03 Cr | -0.25 Cr | 0.02 Cr | 0.05 Cr | 0.03 Cr | -0.03 Cr | 0.30 Cr |
| 2018-06-30 | -19.56 Cr | 1.41 Cr | -0.03 Cr | -1.21 Cr | -0.04 Cr | 0.03 Cr | 0.07 Cr | -0.03 Cr | 1.38 Cr |
| 2018-03-31 | -19.56 Cr | 1.41 Cr | -0.03 Cr | -1.21 Cr | -0.04 Cr | 0.03 Cr | 0.07 Cr | -0.03 Cr | 1.38 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,631.60 | ₹3,914,749,025,765.00 | ₹1,379,917.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,155.00 | ₹1,633,964,230,860.00 | ₹762,656.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹3,573.20 | ₹1,209,331,674,000.00 | ₹150,061.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,235.30 | ₹1,028,229,440,425.00 | ₹1,046,334.00 |
| Mankind Pharma Limited | MANKIND | ₹2,465.20 | ₹1,017,532,229,548.00 | ₹154,021.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹990.30 | ₹996,469,134,258.00 | ₹605,738.00 |
| Lupin Limited | LUPIN | ₹1,910.30 | ₹872,544,555,240.00 | ₹342,085.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,490.00 | ₹656,411,850,000.00 | ₹92,259.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,077.40 | ₹625,755,668,620.00 | ₹413,903.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹1,940.40 | ₹547,582,449,784.00 | ₹222,293.00 |
| Laurus Labs Limited | LAURUSLABS | ₹858.05 | ₹463,196,754,587.00 | ₹667,514.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,078.00 | ₹412,407,234,624.00 | ₹1,177,218.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,353.20 | ₹343,312,547,798.00 | ₹25,161.00 |
| Cohance Lifesciences Limited | COHANCE | ₹862.90 | ₹330,117,185,106.00 | ₹115,797.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,407.60 | ₹300,795,008,342.00 | ₹168,380.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹1,678.90 | ₹262,909,425,657.00 | ₹57,730.00 |
| Piramal Enterprises Limited | PEL | ₹1,124.20 | ₹254,856,250,172.00 | ₹2,148,582.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹9,250.00 | ₹231,250,000,000.00 | ₹8,136.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,393.50 | ₹226,422,570,194.00 | ₹227,014.00 |
| Eris Lifesciences Limited | ERIS | ₹1,600.00 | ₹217,941,686,400.00 | ₹79,397.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹15,560.00 | ₹199,633,072,840.00 | ₹24,589.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹926.40 | ₹182,096,078,074.00 | ₹62,949.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹1,087.00 | ₹172,344,702,208.00 | ₹35,740.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹2,004.40 | ₹152,357,843,462.00 | ₹32,506.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹807.50 | ₹144,631,220,025.00 | ₹238,832.00 |
| Granules India Limited | GRANULES | ₹550.60 | ₹133,613,391,175.00 | ₹526,798.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Procter & Gamble Health Limited | PGHL | ₹6,240.00 | ₹103,580,143,680.00 | ₹4,799.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹838.00 | ₹75,950,428,022.00 | ₹140,634.00 |
| Strides Pharma Science Limited | STAR | ₹798.25 | ₹73,576,868,951.00 | ₹259,913.00 |
| FDC Limited | FDC | ₹449.60 | ₹73,199,413,766.00 | ₹27,135.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹357.70 | ₹69,959,615,583.00 | ₹159,408.00 |
| Sequent Scientific Limited | SEQUENT | ₹217.36 | ₹54,321,056,859.00 | ₹5,922,458.00 |
| Innova Captab Limited | INNOVACAP | ₹829.00 | ₹47,439,466,141.00 | ₹5,952.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹503.75 | ₹45,977,262,500.00 | ₹47,083.00 |
| Suven Life Sciences Limited | SUVEN | ₹201.87 | ₹44,015,875,503.00 | ₹96,915.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹129.06 | ₹41,882,756,147.00 | ₹150,243.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹2,295.00 | ₹37,957,039,425.00 | ₹3,265.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹722.55 | ₹36,647,089,318.00 | ₹22,206.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹361.10 | ₹36,212,012,917.00 | ₹21,843.00 |
| Unichem Laboratories Limited | UNICHEMLAB | ₹473.30 | ₹33,323,041,475.00 | ₹3,351.00 |
| Hikal Limited | HIKAL | ₹250.80 | ₹30,923,828,100.00 | ₹100,235.00 |
| IOL Chemicals and Pharmaceuticals Limited | IOLCP | ₹102.40 | ₹30,057,217,024.00 | ₹1,545,091.00 |
| Indoco Remedies Limited | INDOCO | ₹296.00 | ₹27,279,775,880.00 | ₹21,798.00 |
| Morepen Laboratories Limited | MOREPENLAB | ₹48.11 | ₹26,362,052,459.00 | ₹799,491.00 |
| Alembic Limited | ALEMBICLTD | ₹100.31 | ₹25,757,785,167.00 | ₹159,523.00 |
| Solara Active Pharma Sciences Limited | SOLARA | ₹595.00 | ₹25,446,930,250.00 | ₹61,051.00 |
Key Executives
No executive data available.
FAQs about Syncom Healthcare Limited
What is the current market price of the stock?
The current price is ₹4.25.
What is the 52-week price range?
The range is ₹3.95-4.3.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Syncom Healthcare Limited (ISIN: INE602K01014) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹0.00 crores and an average daily volume of 0 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹0.